EF Johnson Technologies, Inc. Announces First Quarter 2009 Financi...($9 $9 Accounts payab...),Health

Date:5/6/2009

$9 $9 Accounts payable 11,175 11,728 Accrued expenses 8,924 10,786 Billings in excess of cost on uncompleted contracts 970 217 Deferred revenues 665 1,235 Total current liabilities 21,743 23,975 Long-term debt obligations, net of current portion 15,004 15,006 Deferred income taxes 631 631 Other liabilities 987 1,106 TOTAL LIABILITIES 38,365 40,718 Commitments and contingencies Stockholders' equity: Preferred stock ($0.01 par value; 3,000,000 shares authorized; none issued) - - Common stock ($0.01 par value; 50,000,000 voting shares authorized, 26,528,028 and 26,336,735 issued and outstanding as of March 31, 2009 and December 31, 2008, respectively) 262 262 Additional paid-in capital 155,256 154,688 Accumulated other comprehensive loss (969) (1,088) Accumulated deficit (98,119) (96,861) Treasury stock (103,255 and 18,083 shares at cost at March 31, 2009 and December 31, 2008) (118) (32) TOTAL STOCKHOLDERS' EQUITY 56,312 56,969 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $94,677 $97,687 EF JOHNSON TECHNOLOGIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS For the three months ended March 31, 2009 and
'/>"/>

SOURCE EF Johnson Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
7. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
8. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
9. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
10. UAN Mourns Passing of President Cheryl L. Johnson, RN
11. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate